[MDGL] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
15-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- 40.23%
YoY- 48.23%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 0 0 0 0 0 0 7,437 -
PBT -11,475 -8,445 -7,749 -10,536 -20,352 -24,162 -47,380 -21.04%
Tax -25 -276 142 0 0 0 -44,667 -71.27%
NP -11,475 -8,445 -7,749 -10,536 -20,352 -24,162 -18,123 -7.33%
Tax Rate - - - - - - - -
Total Cost 11,475 8,445 7,749 10,536 20,352 24,162 25,560 -12.48%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -243.69 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -0.75 -0.67 -0.67 -2.68 -6.57 -9.90 -9.19 -34.12%
EPS Diluted -0.75 -0.67 -0.67 -2.68 -6.57 -9.90 -9.19 -34.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.